raw ghk-cu face and around the eyes morning and night. GHK-CU – Research Peptide |

Description

Dosage, Administration, and Access Considerations Dosing and administration should be individualized by a qualified healthcare professional

Sermorelin occupies a somewhat more legitimate position: it was FDA-approved as a diagnostic and therapeutic agent for growth hormone deficiency in children and was subsequently withdrawn for commercial rather than safety reasons

It is found in every cell with particularly high concentrations in the liver, spleen, kidney, eye-lens, erythrocytes, and leukocytes

AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily